Log in to save to my catalogue

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: compar...

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: compar...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d27b191a16d84799a9c5014934b2f0a7

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial

About this item

Full title

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial

Publisher

London: EULAR

Journal title

Rheumatic & musculoskeletal diseases open, 2022-07, Vol.8 (2), p.e002366

Language

English

Formats

Publication information

Publisher

London: EULAR

More information

Scope and Contents

Contents

ObjectiveWe used the Study of Etanercept And Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA) data set to examine the impact of presence of enthesitis, dactylitis, nail disease and/or psoriasis on treatment response in patients with early psoriatic arthritis (PsA).MethodsThis post hoc analysis evaluated...

Alternative Titles

Full title

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d27b191a16d84799a9c5014934b2f0a7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d27b191a16d84799a9c5014934b2f0a7

Other Identifiers

ISSN

2056-5933

E-ISSN

2056-5933

DOI

10.1136/rmdopen-2022-002366

How to access this item